GPT-Rosalind: When AI Gets Its Lab Coat On
OpenAI’s new GPT-Rosalind targets life sciences research specifically, marking a shift toward specialized AI tools rather than general-purpose chatbots. This domain-focused approach could accelerate drug discovery and genomics analysis, though human expertise remains essential for validation.